on 27 Feb 2024
Last Applicant/ Owned by
I-20122 MILANO
IT
Serial Number
79359829 filed on 23rd Nov 2022
Registration Number
N/A
Correspondent Address
Theodore R. Remaklus
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Software as a service (SAAS) services featuring software platforms using artificial intelligence for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; providing tempRead More
Software as a service (SAAS) services featuring software platforms using artificial intelligence for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; providing temporary use of online, non-downloadable artificial intelligence computer programs accessible via data networks for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; research in the field of artificial intelligence; design and development of computer software for operating medical technology in the nature of software for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; design and development of virtual screening software; design and development of virtual reality software for teaching medicine
Downloadable computer software for use in identifying new drugs, namely, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; downloadable computer software for use by doctors and other medical professionals in capturing, tracking, reporting, analyzing health data in the field of medical decision support systems; downloadable virtual reality software for medical teaching, specifically, for granting user access to courses of instruction in the medical field; downloadable virtual screening software, specifically, software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, and facilitates proof-of-concept testing in selected pre-clinical models; downloadable collaboration software platforms for use in database management in the field of medicine; downloadable computer software platforms for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models; downloadable artificial intelligence software for identifying new drugs in the nature of software that is able to screen billions of compounds in a very short time and allows the identification of molecular targets, the identification and validation of candidate molecules, the proof-of-concept testing in selected pre-clinical models in the field of healthcare
No 79359829
No Service Mark
No BUGNION-251
No
No
No
No
Yes
Yes
No
No
26.19.04 -
Cubes
The mark consists of the word "EXSCALATE" in black, to the left of which appears a red, dark red, and light red cube design outlined in black, the rear of which is a square shape while the front shape is that of an X. White indicates transparent matter and is not claimed as a feature of the mark.
| Status Date | Action Taken |
|---|---|
| 27th Feb 2024 | PUBLISHED FOR OPPOSITION |
| 26th Feb 2024 | NOTIFICATION PROCESSED BY IB |
| 07th Feb 2024 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| 07th Feb 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 07th Feb 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 07th Feb 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 23rd Jan 2024 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| 11th Jan 2024 | EXAMINERS AMENDMENT -WRITTEN |
| 11th Jan 2024 | EXAMINERS AMENDMENT E-MAILED |
| 11th Jan 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
